MFSD4A: A Potential Drug Target for Immune and Cancer Errors (G148808)

Target Name: MFSD4A

NCBI ID: G148808

MFSD4A

MFSD4A: A Potential Drug Target for Immune and Cancer Errors

MFSD4A (MFD4A_HUMAN), also known as human MFSD4A, is a gene that encodes a protein known as MFSD4A. The MFSD4A protein is a key regulator of the immune response and has been linked to a number of autoimmune diseases. As a result, MFSD4A has emerged as a promising drug target and biomarker for a variety of diseases.

MFSD4A is a member of the Mucin and tissue factor superfamily (MASF), which includes a group of genes that are involved in the regulation of extracellular matrix (ECM) components. The MASF genes are characterized by the presence of a transmembrane domain, a cytoplasmic domain, and a carboxylic acid-rich region (CAR) that is involved in protein-protein interactions.

MFSD4A is expressed in a variety of tissues and cells, including immune cells, epithelial cells, and cancer cells. It has been shown to play a role in the regulation of immune cell function, including the T cell response to infection and inflammation. MFSD4A has has also been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway.

One of the key functions of MFSD4A is its role in the regulation of T cell development and function. T cells are a critical part of the immune system and play a key role in fighting off infections and diseases. MFSD4A has been shown to be involved in the regulation of T cell development and function by regulating the production of T cells from stem cells and the activation and proliferation of T cells.

In addition to its role in T cell development, MFSD4A has also been shown to be involved in the regulation of cancer cell growth and survival. MFSD4A has been shown to be involved in the regulation of cancer cell migration and the development of cancer-induced immune evasion.

MFSD4A has also been shown to be involved in the regulation of inflammation and autoimmune diseases. MFSD4A has been shown to be involved in the regulation of inflammation by regulating the production of pro-inflammatory cytokines.

In conclusion, MFSD4A is a protein that has been shown to play a critical role in a variety of biological processes, including immune function, cancer growth and survival, and inflammation. As a result, MFSD4A has emerged as a promising drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of MFSD4A in these processes and to develop effective treatments for a range of diseases.

Protein Name: Major Facilitator Superfamily Domain Containing 4A

The "MFSD4A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MFSD4A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets